#166: Was Mounjaro, Ozempic, Wegovy wirklich können

from Die Biohacking-Praxis · host The Red Bulletin

Das Update zu GLP-1-Antagonisten: mit erstaunlichen Studien zur Wirkung auf Entzündungen (!), Gehirngesundheit (!!) und Sucht (!!!), mit atemberaubenden Marktperspektiven, mit Tipps zur richtigen Einnahme. Und mit einer klaren Risiko-Einschätzung.

Episode metadata supplied by the publisher feed · Published May 6, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

#166: Was Mounjaro, Ozempic, Wegovy wirklich können

0:00 38:43

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Die Biohacking-Praxis?

This episode is 38 minutes long.

When was this Die Biohacking-Praxis episode published?

This episode was published on May 6, 2025.

Can I download this Die Biohacking-Praxis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!